These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Heterogeneous patterns of CEBPalpha mutation status in the progression of myelodysplastic syndrome and chronic myelomonocytic leukemia to acute myelogenous leukemia. Shih LY; Huang CF; Lin TL; Wu JH; Wang PN; Dunn P; Kuo MC; Tang TC Clin Cancer Res; 2005 Mar; 11(5):1821-6. PubMed ID: 15756005 [TBL] [Abstract][Full Text] [Related]
11. Chronic myelomonocytic leukemia: molecularly contaminated, but not defined. Patnaik MM; Tefferi A Leuk Lymphoma; 2016 Aug; 57(8):1751-2. PubMed ID: 27063331 [No Abstract] [Full Text] [Related]
12. Clinical significance of CSF3R, SRSF2 and SETBP1 mutations in chronic neutrophilic leukemia and chronic myelomonocytic leukemia. Ouyang Y; Qiao C; Chen Y; Zhang SJ Oncotarget; 2017 Mar; 8(13):20834-20841. PubMed ID: 28209919 [TBL] [Abstract][Full Text] [Related]
13. Low frequency of ras oncogene mutations in Philadelphia-positive acute leukemia and report of a novel mutation H61 Leu in a single case. Urbano-Ispizua A; Gill R; Matutes E; Levi S; Wiedemann LM; Catovsky D; Marshall CJ Leukemia; 1992 Apr; 6(4):342-6. PubMed ID: 1588796 [TBL] [Abstract][Full Text] [Related]
14. KRAS mutations, autoimmunity and female sex in chronic myelomonocytic leukemia. Osman AEG; Rets A; Patel AB Leuk Res; 2024 Mar; 138():107466. PubMed ID: 38430640 [No Abstract] [Full Text] [Related]
16. SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemias. Damm F; Itzykson R; Kosmider O; Droin N; Renneville A; Chesnais V; Gelsi-Boyer V; de Botton S; Vey N; Preudhomme C; Clavert A; Delabesse E; Park S; Birnbaum D; Fontenay M; Bernard OA; Solary E Leukemia; 2013 Jun; 27(6):1401-3. PubMed ID: 23443343 [No Abstract] [Full Text] [Related]
17. Analysis of immunohistochemical results of the ras oncogene product p21 in myelodysplastic syndromes. Kalmantis T; Kalmanti M; Vassilaki M; Spandidos DA Anticancer Res; 1993; 13(4):1103-6. PubMed ID: 8352532 [TBL] [Abstract][Full Text] [Related]
18. p53 Protein expression in chronic myelomonocytic leukemia-1 correlates with progression to leukemia and a poor prognosis. Hattori N; Fukuchi K; Nakamaki T; Homma M; Ariizumi H; Nakashima H; Maeda T; Saito B; Yamochi-Onizuka T; Yanagisawa K; Matsuda I; Ota H; Tomoyasu S Acta Haematol; 2011; 125(4):242-6. PubMed ID: 21335959 [No Abstract] [Full Text] [Related]
19. RET fusion genes are associated with chronic myelomonocytic leukemia and enhance monocytic differentiation. Ballerini P; Struski S; Cresson C; Prade N; Toujani S; Deswarte C; Dobbelstein S; Petit A; Lapillonne H; Gautier EF; Demur C; Lippert E; Pages P; Mansat-De Mas V; Donadieu J; Huguet F; Dastugue N; Broccardo C; Perot C; Delabesse E Leukemia; 2012 Nov; 26(11):2384-9. PubMed ID: 22513837 [TBL] [Abstract][Full Text] [Related]
20. Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia. Boultwood J; Perry J; Pellagatti A; Fernandez-Mercado M; Fernandez-Santamaria C; Calasanz MJ; Larrayoz MJ; Garcia-Delgado M; Giagounidis A; Malcovati L; Della Porta MG; Jädersten M; Killick S; Hellström-Lindberg E; Cazzola M; Wainscoat JS Leukemia; 2010 May; 24(5):1062-5. PubMed ID: 20182461 [No Abstract] [Full Text] [Related] [Next] [New Search]